Home › Orasure Technologies Receives FDA Emergency Use Authorization for Ebola Rapid Diagnostic Test
 

Keywords :   


Orasure Technologies Receives FDA Emergency Use Authorization for Ebola Rapid Diagnostic Test

2015-08-03 19:27:07| Biotech - Topix.net

OraSure Technologies, Inc. , a leader in point of care diagnostic tests and specimen collection devices, announced today that it has received a U.S. Food and Drug Administration Emergency Use Authorization for its OraQuick Ebola Rapid Antigen Test for use with fingerstick and venous whole blood. This test has not been cleared or approved by FDA.

Tags: test technologies rapid emergency

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.06Eastern North Pacific Tropical Weather Outlook
02.06Atlantic Tropical Weather Outlook
02.06Eastern North Pacific Tropical Weather Outlook
02.06Atlantic Tropical Weather Outlook
02.06Weekly Recap: Dyper Names CEO, Soft N Dry Diapers Expand Distribution to Brazil & More
02.06Atlantic Tropical Weather Outlook
02.06Eastern North Pacific Tropical Weather Outlook
02.06Shops rush for Christmas stock as shipping costs surge
More »